NCT00306618 2008-12-10Safety and Efficacy Study of Panzem NCD to Treat GlioblastomaCASI Pharmaceuticals, Inc.Phase 2 Completed27 enrolled
NCT00481455 2008-11-25Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)CASI Pharmaceuticals, Inc.Phase 2 Completed15 enrolled